COSM · XBRL financial data

Cosmos Health financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (COSM's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	12,824	15,840*	14,584	13,207	12,411	14,224*	13,713	14,746	17,110	19,703*	17,928	18,986
Cost of goods and services sold	11,609	14,609*	13,251	12,439	11,204	13,221*	11,663	13,582	14,508	17,624*	16,547	17,475
Gross profit	1,215	1,231*	1,334	767	1,207	1,004*	2,050	1,164	2,603	2,079*	1,381	1,512
Research and development	—	year only	0	0	0	533*	16	75	18	411*	0	69
General and administrative	2,573	12,979*	1,418	1,391	1,783	7,142*	1,479	1,490	2,040	10,610*	1,800	2,066
Total operating expenses	4,232	14,817*	3,170	3,269	3,447	9,970*	2,883	3,809	4,421	13,486*	3,565	4,437
Operating income (loss)	(3,017)	(13,586)*	(1,836)	(2,502)	(2,240)	(8,967)*	(833)	(2,645)	(1,819)	(11,406)*	(2,184)	(2,926)
Interest expense	151	337*	169	342	181	320*	187	389	669	655*	423	602
Other income (expense)	14	(52)*	192	(29)	(2)	(74)*	(68)	(42)	(6)	(118)*	441	38
Income tax expense (benefit)	66	0*	0	0	0	0*	0	0	0	0*	0	0
Net income (loss)	(3,349)	(13,752)*	(1,867)	(2,591)	(2,183)	(9,543)*	(818)	(2,828)	(5,353)	(10,146)*	(2,805)	(6,087)
Earnings per share, basic USD per share	(0.27)	—	(0.11)	(0.15)	(0.45)	(0.41)*	(0.03)	(0.10)	(0.17)	(0.28)*	(0.06)	(0.10)
Earnings per share, diluted USD per share	(0.27)	—	(0.11)	(0.15)	(0.45)	—	(0.03)	(0.10)	(0.17)	(0.28)*	(0.06)	(0.10)
Weighted average shares, basic thousands of shares	12,585	—	16,852	17,834	18,418	23,448*	26,038	28,753	30,625	35,631*	47,088	59,923
Weighted average shares, diluted thousands of shares	12,585	—	16,852	17,834	18,418	23,448*	26,038	28,753	30,625	35,631*	47,088	59,923

Balance sheet

CSV

Fiscal quarters (COSM's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	2,361	3,833	865	344	3,315	315	743	656	889	716	515	1,801
Marketable securities	18	20	21	22	23	21	25	30	33	46	34	37
Accounts receivable	25,591	19,759	19,070	18,383	17,484	13,478	14,252	15,456	18,029	19,629	18,187	18,861
Inventory	5,960	4,789	4,871	4,324	4,885	4,355	4,736	5,111	5,684	5,778	5,650	4,519
Prepaid and other current assets	3,048	1,812	1,896	2,100	1,915	1,310	1,383	1,638	1,658	2,007	2,336	2,809
Total current assets	46,487	36,608	34,287	33,415	36,239	25,461	27,845	30,562	38,104	38,388	36,889	36,669
Property and equipment, net	10,250	10,455	10,170	10,054	10,576	9,690	10,016	10,820	10,665	10,579	10,280	10,140
Right-of-use asset	798	1,132	773	727	711	696	672	670	654	597	669	639
Goodwill	50	50	50	50	50	50	50	50	50	50	50	50
Total assets	71,525	66,015	62,345	60,827	64,520	54,312	57,192	61,836	69,493	65,478	62,369	61,462
Accrued liabilities	83	166	—	165	186	222	—	—	—	—	—	—
Total current liabilities	22,585	24,322	23,556	24,821	25,211	25,758	26,586	31,167	38,534	38,272	34,077	34,843
Long-term debt	—	1,327	1,214	—	—	—	—	—	—	—	—	—
Lease liability, non-current	628	845	509	472	468	498	467	453	428	373	463	432
Total liabilities	26,957	29,972	27,799	28,708	29,543	29,779	31,240	35,604	46,358	47,053	42,543	40,787
Accumulated deficit	(71,038)	(91,644)	(93,511)	(96,102)	(104,479)	(114,022)	(114,840)	(117,668)	(123,021)	(133,167)	(135,973)	(142,059)
Total stockholders' equity	44,196	36,043	34,547	32,120	34,977	24,533	25,952	26,232	23,135	18,425	19,826	20,674
Total liabilities and equity	71,525	66,015	62,345	60,827	64,520	54,312	57,192	61,836	69,493	65,478	62,369	61,462
Common shares outstanding (cover page) thousands of shares	13,404	17,606	17,834	17,834	23,346	27,285	28,751	30,214	34,920	50,825	54,428	100,634

Cash flows

CSV

Fiscal quarters (COSM's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(3,349)	(13,752)*	(1,867)	(2,591)	(2,183)	(9,543)*	(818)	(2,828)	(5,353)	(10,146)*	(2,805)	(6,087)
Stock-based compensation	110*	363*	340	340*	423*	587*	557	603*	571*	582*	536	559*
Depreciation and amortization	—	—	312	—	—	305*	316	354*	376*	315*	347	348*
Net cash from operating activities	(4,524)*	952*	(3,412)	(1,211)*	740*	(3,834)*	(186)	(1,210)*	(2,455)*	(4,596)*	(1,067)	(1,718)*
Purchases of property and equipment	17*	47*	83	34*	229*	72*	13	23*	13*	8*	11	64*
Net cash from investing activities	(1,952)*	(3,361)*	126	116*	(35)*	(1,005)*	(7)	72*	(1,010)*	(1,070)*	(709)	115*
Proceeds from issuing common stock	5,200*	(9,950)*	649	—	—	0*	0	0*	1,022*	4,395*	1,833	1,109*
Share repurchases	—	0*	—	—	—	0*	—	—	—	—	—	—
Net cash from financing activities	6,343*	4,292*	207	540*	2,680*	1,620*	561	1,604*	7,192*	4,699*	348	1,789*
Net change in cash	128*	1,473*	(2,968)	(522)*	2,971*	(3,000)*	428	(87)*	3,978*	(1,174)*	(1,301)	286*

Compare with peers

SIC 5122 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 5122 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Cosmos Health	1,801	18,986	(1,718)*	100.6M	1.1 quarters	Q2 FY26 10-QJun 30, 2026
Stemtech	247	629	(55)*	3.0B	4.5 quarters	Q2 FY26 10-QJun 30, 2026
DataMeds AI	2,456	1,780	(2,894)*	3.1M	0.8 quarters	Q2 FY26 10-QJun 30, 2026
HWH International	1,506	64	478*	7.7M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.